Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference29 articles.
1. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial;KS Albain;Lancet Oncol,2010
2. St. Gallen 2011: Summary of the Consensus Discussion;M Gnant;Breast Care (Basel),2011
3. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011;A Goldhirsch;Ann Oncol,2011
4. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer;S Paik;J Clin Oncol,2006
5. Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial;KS Albain;Lancet,2009
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Use and accuracy of decision support systems using artificial intelligence for tumor diseases: a systematic review and meta-analysis;Frontiers in Oncology;2023-10-04
2. Physicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries;JMIR Cancer;2022-04-07
3. A Deep Neural Network for Estimating Low-Density Lipoprotein Cholesterol From Electronic Health Records: Real-Time Routine Clinical Application;JMIR Medical Informatics;2021-08-03
4. Multicenter randomized comparative trial of Micromedex, Micromedex with Watson, or Google to answer drug information questions;Journal of the Medical Library Association;2021-07-20
5. A Roadmap towards Breast Cancer Therapies Supported by Explainable Artificial Intelligence;Applied Sciences;2021-05-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3